SpectraWAVE Secures $50M to Improve Treatment for Coronary Artery Disease nextdigitalhealth.com

A medical imaging company providing technology solutions to improve treatment for people with coronary artery disease, SpectraWAVE, Inc., has secured $50 million in Series B funding round to support commercial expansion and the addition of new products.

Co-founded in 2017 by Guillermo Tearney, and Gregg Stone, SpectraWAVE has developed an intravascular imaging technology, HyperVue™ Imaging System, which leverages photonics to improve the outcomes for coronary artery disease patients.